Pacritinib

CAS No.:937272-79-2

TBW04399
Pacritinib;(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaene;Pacritinib (SB1518);Pacritinib​;SB1518;SB-1518;(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene;Pacritinib(SB1518);G22N65IL3O;SB 1518;SB1518(Pacritinib);Pacritinib [USAN:INN];GTPL7793;AOB87797;Pacritinib(SB1518
inquiry
C28H32N4O3
472.58

Product introduction

Category: Drug Impurities and Intermediates
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: O(C1C([H])=C([H])C2=C([H])C=1C([H])([H])OC([H])([H])C([H])=C([H])C([H])([H])OC([H])([H])C1C([H])=C([H])C([H])=C(C=1[H])C1C([H])=C([H])N=C(N=1)N2[H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] |t:19|